Latest Market Making News

Firebrick Pharma has received a $293,000 R&D Tax Incentive payment linked to $673,000 of eligible development spending on new Nasodine products. The non-dilutive cash arrives as the company broadens its product range and pursues approvals in additional markets.

ReNerve has converted regulatory approvals into its first commercial NervAlign Nerve Cuff surgeries in Hong Kong and Malaysia, expanding activity to seven jurisdictions. The milestones arrive as FY26 sales climbed 88% to $510,357 and the company builds out its US distribution network.

Magellan Infrastructure Fund (Currency Hedged) reported a $73.9 million profit for FY2026, down from $108.1 million the prior year, while boosting distributions to unitholders by over 270%.

Biotron has received pivotal regulatory feedback from the European Medicines Agency ruling out a Hybrid Marketing Authorisation for SedRx, prompting plans for pivotal clinical trials. The company also advances its lead antiviral candidate BIT-HBV001 against Hepatitis Delta Virus and appoints a new chairman.

Enlitic’s Ensight platform goes live at New Zealand’s largest private radiology provider, marking a milestone in its Intelerad partnership and expanding its global footprint after record contract wins.

Magellan Asset Management is shifting its flagship MGOC ETF to a new systematic equity strategy managed by Vinva Investment Management, slashing fees and eliminating performance charges.

Temas Resources has fortified its position in the critical minerals sector through key strategic moves including joining Québec’s CSM Scientific Network, engaging market-making services, and commissioning independent equity research.

Magellan Investment Partners has launched the Magellan Global Equities Fund (Currency Hedged), an actively managed ETF listed on the ASX under ticker MHG, targeting a 9% annual return with integrated ESG considerations.

Magellan Investment Partners has launched the Airlie Australian Share Fund - Active ETF (AASF), offering investors a concentrated, actively managed portfolio of Australian equities with integrated ESG considerations. The fund combines liquidity via direct applications and Securities Exchange trading, targeting long-term capital growth and income.

Fidante Partners has issued a replacement Product Disclosure Statement for the Alphinity Global Sustainable Equity Fund - Active ETF, refining ESG disclosures and noting a rise in transaction costs. The Fund’s core investment approach and fees remain steady.

West Cobar Metals has identified significant gallium mineralisation across its Salazar Critical Minerals Project in Western Australia, highlighting potential co-product recovery alongside rare earth elements and scandium. This discovery comes amid tightening global gallium supply due to Chinese export restrictions.

Resouro Strategic Metals has engaged Independent Trading Group to provide market-making services on the TSX Venture Exchange, aiming to enhance liquidity and trading efficiency for its shares. This move comes as the company continues to advance its significant Brazilian mineral projects.